Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Izotropic ( (TSE:IZO) ) has shared an announcement.
Izotropic has announced the timelines and milestones for the launch of its first medical imaging device, the IzoView Breast CT Imaging System, designed to improve breast cancer screening particularly for patients with dense breast tissue. The clinical study for FDA approval will be conducted across three U.S. sites, and the company plans to announce the development of two new medical imaging devices within the next year, aiming to enhance its market position and valuation.
More about Izotropic
Izotropic Corporation is a medical device company that specializes in developing imaging-based products utilizing innovative and emerging technologies for more accurate screening, diagnosis, and treatment of breast cancers.
YTD Price Performance: 240.0%
Average Trading Volume: 53,097
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $9.07M
See more data about IZO stock on TipRanks’ Stock Analysis page.
